Molecular Detection

About:

Molecular Detection develops a portfolio of sample-to-answer molecular diagnostic tests for detecting infectious diseases.

Website: http://www.detect-ready.com

Top Investors: Tech Coast Angels, MentorTech Ventures, Mid-Atlantic Angel Group, Robin Hood Ventures, Elm Spring

Description:

Molecular Detection Inc. (MDI) is developing and commercializing a portfolio of "sample-to-answer" Detect-Readyâ„¢ molecular diagnostic tests for the rapid detection of infectious diseases. The company is preparing to launch its first product, the Detect-Ready assay for the rapid detection of methicillin-resistant Staphylococcus aureus (MRSA), a growing problem among hospitals and other health facilities around the globe.

Total Funding Amount:

$8.25M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Wayne, Pennsylvania, United States

Founded Date:

2007-01-01

Contact Email:

corporate(AT)detect-ready.com

Founders:

Aryeh L. Gassel

Number of Employees:

11-50

Last Funding Date:

2013-12-01

IPO Status:

Private

Industries:

© 2025 bioDAO.ai